Executive Briefing Series (formerly The Food & Drug Letter)
June 29, 2012
FDA Warns on Counterfeit Adderall Entering U.S. Via Internet Pharmacies
Rogue online pharmacies looking to cash in on drugs in short supply are peddling counterfeit versions of Teva’s attention-deficit/hyperactivity disorder drug Adderall, the FDA warns.
This article is viewable by subscribers only. To view this article, please select an option below.
|